Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Protilo is a multi-ingredient nutritional supplement powder developed and marketed by Prisure Medicare, an Indian pharmaceutical company. The product is formulated with a blend of active ingredients including protein, bovine colostrum, docosahexaenoic acid (DHA), omega-3 fatty acids derived from flaxseed, and gamma-linolenic acid (GLA). It also contains a comprehensive profile of essential vitamins (A, B-complex, C, D2) and minerals (calcium, iron, copper, manganese). Protilo is indicated for supporting overall nutrition, managing nutritional deficiencies, boosting immune function, and promoting growth and vitality across various age groups, including children, adults, and the elderly. It is available in multiple flavors and specialized versions, such as Protilo SF (sugar-free) and Protilo DM (diabetes management).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Protilo.